Patent 7345069 was granted and assigned to Wisconsin Alumni Research Foundation on March, 2008 by the United States Patent and Trademark Office.
The present invention relates to TG-25 and/or analogs thereof and their use of TG-25 in the treatment of cancer. TG-25 inhibits the growth of prostate cells by inhibiting DNA synthesis, more particularly by DNA cleavage.